Free Trial

TSR (TSRI) Competitors

TSR logo
$13.38 0.00 (0.00%)
As of 05/4/2026

TSRI vs. DH, RAAS, CSPI, ARBE, and HCAT

Should you be buying TSR stock or one of its competitors? The main competitors of TSR include Definitive Healthcare (DH), Cloopen Group (RAAS), CSP (CSPI), Arbe Robotics (ARBE), and Health Catalyst (HCAT). These companies are all part of the "computer software" industry.

How does TSR compare to Definitive Healthcare?

TSR (NASDAQ:TSRI) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Definitive Healthcare has a consensus price target of $3.27, suggesting a potential upside of 239.96%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than TSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Definitive Healthcare
3 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00

9.7% of TSR shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 30.2% of TSR shares are held by insiders. Comparatively, 14.8% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Definitive Healthcare had 3 more articles in the media than TSR. MarketBeat recorded 3 mentions for Definitive Healthcare and 0 mentions for TSR. Definitive Healthcare's average media sentiment score of 0.51 beat TSR's score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
TSR Neutral
Definitive Healthcare Positive

TSR has a net margin of 2.15% compared to Definitive Healthcare's net margin of -57.52%. TSR's return on equity of 11.21% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
TSR2.15% 11.21% 7.97%
Definitive Healthcare -57.52%2.63%1.39%

TSR has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than TSR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TSR$88.82M0.33$1.74M$0.8515.74
Definitive Healthcare$241.52M0.42-$138.93M-$1.25N/A

TSR has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500.

Summary

Definitive Healthcare beats TSR on 10 of the 17 factors compared between the two stocks.

How does TSR compare to Cloopen Group?

TSR (NASDAQ:TSRI) and Cloopen Group (NYSE:RAAS) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

9.7% of TSR shares are owned by institutional investors. 30.2% of TSR shares are owned by company insiders. Comparatively, 9.8% of Cloopen Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, TSR's average media sentiment score of 0.00 equaled Cloopen Group'saverage media sentiment score.

Company Overall Sentiment
TSR Neutral
Cloopen Group Neutral

TSR has higher revenue and earnings than Cloopen Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TSR$88.82M0.33$1.74M$0.8515.74
Cloopen Group$78.58M0.85-$19.56MN/AN/A

TSR has a net margin of 2.15% compared to Cloopen Group's net margin of 0.00%. TSR's return on equity of 11.21% beat Cloopen Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TSR2.15% 11.21% 7.97%
Cloopen Group N/A N/A N/A

Summary

TSR beats Cloopen Group on 7 of the 8 factors compared between the two stocks.

How does TSR compare to CSP?

CSP (NASDAQ:CSPI) and TSR (NASDAQ:TSRI) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

26.7% of CSP shares are owned by institutional investors. Comparatively, 9.7% of TSR shares are owned by institutional investors. 15.0% of CSP shares are owned by insiders. Comparatively, 30.2% of TSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, CSP had 1 more articles in the media than TSR. MarketBeat recorded 1 mentions for CSP and 0 mentions for TSR. CSP's average media sentiment score of 0.88 beat TSR's score of 0.00 indicating that CSP is being referred to more favorably in the media.

Company Overall Sentiment
CSP Positive
TSR Neutral

TSR has higher revenue and earnings than CSP. CSP is trading at a lower price-to-earnings ratio than TSR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CSP$58.73M1.59-$90K-$0.05N/A
TSR$88.82M0.33$1.74M$0.8515.74

CSP has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, TSR has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

TSR has a net margin of 2.15% compared to CSP's net margin of -0.87%. TSR's return on equity of 11.21% beat CSP's return on equity.

Company Net Margins Return on Equity Return on Assets
CSP-0.87% -1.04% -0.70%
TSR 2.15%11.21%7.97%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CSP
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
TSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

TSR beats CSP on 8 of the 14 factors compared between the two stocks.

How does TSR compare to Arbe Robotics?

Arbe Robotics (NASDAQ:ARBE) and TSR (NASDAQ:TSRI) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

33.4% of Arbe Robotics shares are held by institutional investors. Comparatively, 9.7% of TSR shares are held by institutional investors. 30.2% of TSR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Arbe Robotics' average media sentiment score of 1.25 beat TSR's score of 0.00 indicating that Arbe Robotics is being referred to more favorably in the media.

Company Overall Sentiment
Arbe Robotics Positive
TSR Neutral

TSR has higher revenue and earnings than Arbe Robotics. Arbe Robotics is trading at a lower price-to-earnings ratio than TSR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arbe Robotics$1.03M98.12-$46.42M-$0.41N/A
TSR$88.82M0.33$1.74M$0.8515.74

Arbe Robotics has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, TSR has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.

TSR has a net margin of 2.15% compared to Arbe Robotics' net margin of -4,402.73%. TSR's return on equity of 11.21% beat Arbe Robotics' return on equity.

Company Net Margins Return on Equity Return on Assets
Arbe Robotics-4,402.73% -82.00% -57.89%
TSR 2.15%11.21%7.97%

Arbe Robotics currently has a consensus price target of $2.25, indicating a potential upside of 173.06%. Given Arbe Robotics' stronger consensus rating and higher possible upside, analysts clearly believe Arbe Robotics is more favorable than TSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbe Robotics
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
TSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

TSR beats Arbe Robotics on 8 of the 15 factors compared between the two stocks.

How does TSR compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and TSR (NASDAQ:TSRI) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

TSR has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than TSR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.38-$177.97M-$2.54N/A
TSR$88.82M0.33$1.74M$0.8515.74

In the previous week, Health Catalyst had 5 more articles in the media than TSR. MarketBeat recorded 5 mentions for Health Catalyst and 0 mentions for TSR. Health Catalyst's average media sentiment score of 0.22 beat TSR's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media.

Company Overall Sentiment
Health Catalyst Neutral
TSR Neutral

TSR has a net margin of 2.15% compared to Health Catalyst's net margin of -57.20%. TSR's return on equity of 11.21% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-57.20% -4.30% -2.16%
TSR 2.15%11.21%7.97%

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 9.7% of TSR shares are held by institutional investors. 2.6% of Health Catalyst shares are held by insiders. Comparatively, 30.2% of TSR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Health Catalyst currently has a consensus price target of $2.80, indicating a potential upside of 74.72%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than TSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.23
TSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Health Catalyst has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, TSR has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.

Summary

Health Catalyst beats TSR on 9 of the 16 factors compared between the two stocks.

Get TSR News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSRI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSRI vs. The Competition

MetricTSRCustom computer programming services IndustryComputer SectorNASDAQ Exchange
Market Cap$29.04M$644.93M$37.05B$11.77B
Dividend YieldN/AN/A3.20%5.26%
P/E Ratio15.742.62163.9027.07
Price / Sales0.330.87619.5273.47
Price / Cash14.2811.8245.7453.90
Price / Book1.741.159.296.69
Net Income$1.74M-$3.93M$1.03B$332.64M
7 Day PerformanceN/A-0.01%4.88%2.01%
1 Month PerformanceN/A-7.30%14.33%9.19%
1 Year PerformanceN/A-16.42%168.78%39.59%

TSR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSRI
TSR
N/A$13.38
flat
N/AN/A$29.04M$88.82M15.74630
DH
Definitive Healthcare
3.5185 of 5 stars
$1.00
-1.2%
$3.27
+227.8%
N/A$105.78M$241.52MN/A970
RAAS
Cloopen Group
N/A$1.85
flat
N/AN/A$102.90M$78.58MN/A1,107
CSPI
CSP
0.316 of 5 stars
$10.09
-0.7%
N/AN/A$100.03M$55.10MN/A120
ARBE
Arbe Robotics
1.8604 of 5 stars
$0.78
+1.4%
$2.25
+188.5%
N/A$95.67M$1.03MN/A120

Related Companies and Tools


This page (NASDAQ:TSRI) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners